Insider Terminal | SEC Intelligence

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
VIR S Vir Biotechnology, Inc. SATO VICKI L • Director 10b5-1 Sell 2026-03-02 $209,181x2 View Form 4 →
VIR	Vir Biotechnology, Inc.	SATO VICKI L Director 10b5-1 Sell	2026-03-02	$209,181x2	S	Form 4
VIR S Vir Biotechnology, Inc. de Verneuil Vanina • Officer • EVP, General Counsel, Corp Sec 10b5-1 SellΔOwn -10.8% 2026-02-25 $134,534 View Form 4 →
VIR	Vir Biotechnology, Inc.	de Verneuil Vanina Officer • EVP, General Counsel, Corp Sec 10b5-1 SellΔOwn -10.8%	2026-02-25	$134,534	S	Form 4
VIR S Vir Biotechnology, Inc. Eisner Mark • Officer • EVP and Chief Medical Officer 10b5-1 Sell 2026-02-25 $18,550 View Form 4 →
VIR	Vir Biotechnology, Inc.	Eisner Mark Officer • EVP and Chief Medical Officer 10b5-1 Sell	2026-02-25	$18,550	S	Form 4
VIR S Vir Biotechnology, Inc. De Backer Marianne • CEO Sell to Cover 2026-02-24 $140,720 View Form 4 →
VIR	Vir Biotechnology, Inc.	De Backer Marianne CEO Sell to Cover	2026-02-24	$140,720	S	Form 4
VIR S Vir Biotechnology, Inc. de Verneuil Vanina • Officer • EVP, General Counsel, Corp Sec Sell to Cover 2026-02-24 $29,713 View Form 4 →
VIR	Vir Biotechnology, Inc.	de Verneuil Vanina Officer • EVP, General Counsel, Corp Sec Sell to Cover	2026-02-24	$29,713	S	Form 4
VIR S Vir Biotechnology, Inc. Eisner Mark • Officer • EVP and Chief Medical Officer Sell to Cover 2026-02-24 $15,405 View Form 4 →
VIR	Vir Biotechnology, Inc.	Eisner Mark Officer • EVP and Chief Medical Officer Sell to Cover	2026-02-24	$15,405	S	Form 4
VIR S Vir Biotechnology, Inc. O'Byrne Jason • CFO Sell to Cover 2026-02-24 $15,576 View Form 4 →
VIR	Vir Biotechnology, Inc.	O'Byrne Jason CFO Sell to Cover	2026-02-24	$15,576	S	Form 4
VIR S Vir Biotechnology, Inc. Sabatini Brent • Officer • SVP, Chief Accounting Officer Sell to Cover 2026-02-24 $13,632 View Form 4 →
VIR	Vir Biotechnology, Inc.	Sabatini Brent Officer • SVP, Chief Accounting Officer Sell to Cover	2026-02-24	$13,632	S	Form 4
VIR S Vir Biotechnology, Inc. SATO VICKI L • Director 10b5-1 Sell 2026-02-24 $413,366x2 View Form 4 →
VIR	Vir Biotechnology, Inc.	SATO VICKI L Director 10b5-1 Sell	2026-02-24	$413,366x2	S	Form 4
VIR S Vir Biotechnology, Inc. De Backer Marianne • CEO Sell to Cover 2026-02-23 $141,894 View Form 4 →
VIR	Vir Biotechnology, Inc.	De Backer Marianne CEO Sell to Cover	2026-02-23	$141,894	S	Form 4
VIR S Vir Biotechnology, Inc. de Verneuil Vanina • Officer • EVP, General Counsel, Corp Sec Sell to Cover 2026-02-23 $33,128 View Form 4 →
VIR	Vir Biotechnology, Inc.	de Verneuil Vanina Officer • EVP, General Counsel, Corp Sec Sell to Cover	2026-02-23	$33,128	S	Form 4
VIR S Vir Biotechnology, Inc. Eisner Mark • Officer • EVP and Chief Medical Officer Sell to Cover 2026-02-23 $15,569 View Form 4 →
VIR	Vir Biotechnology, Inc.	Eisner Mark Officer • EVP and Chief Medical Officer Sell to Cover	2026-02-23	$15,569	S	Form 4
VIR S Vir Biotechnology, Inc. O'Byrne Jason • CFO Sell to Cover 2026-02-23 $15,569 View Form 4 →
VIR	Vir Biotechnology, Inc.	O'Byrne Jason CFO Sell to Cover	2026-02-23	$15,569	S	Form 4
VIR S Vir Biotechnology, Inc. Sabatini Brent • Officer • SVP, Chief Accounting Officer Sell to Cover 2026-02-23 $13,631 View Form 4 →
VIR	Vir Biotechnology, Inc.	Sabatini Brent Officer • SVP, Chief Accounting Officer Sell to Cover	2026-02-23	$13,631	S	Form 4
VIR S Vir Biotechnology, Inc. Sabatini Brent • Officer • SVP, Chief Accounting Officer Sell to Cover 2026-02-13 $11,919 View Form 4 →
VIR	Vir Biotechnology, Inc.	Sabatini Brent Officer • SVP, Chief Accounting Officer Sell to Cover	2026-02-13	$11,919	S	Form 4
VIR S Vir Biotechnology, Inc. SATO VICKI L • Director 10b5-1 Sell 2026-02-02 $169,671 View Form 4 →
VIR	Vir Biotechnology, Inc.	SATO VICKI L Director 10b5-1 Sell	2026-02-02	$169,671	S	Form 4
VIR S Vir Biotechnology, Inc. SATO VICKI L • Director 10b5-1 Sell 2025-12-01 $132,070 View Form 4 →
VIR	Vir Biotechnology, Inc.	SATO VICKI L Director 10b5-1 Sell	2025-12-01	$132,070	S	Form 4
VIR S Vir Biotechnology, Inc. SVF Endurance (Cayman) Ltd • 10% Owner 10b5-1 Sell 2025-12-01 $1,147,786Large View Form 4 →
VIR	Vir Biotechnology, Inc.	SVF Endurance (Cayman) Ltd 10% Owner 10b5-1 Sell	2025-12-01	$1,147,786Large	S	Form 4
VIR S Vir Biotechnology, Inc. SVF Endurance (Cayman) Ltd • 10% Owner 10b5-1 Sell 2025-11-28 $396,015 View Form 4 →
VIR	Vir Biotechnology, Inc.	SVF Endurance (Cayman) Ltd 10% Owner 10b5-1 Sell	2025-11-28	$396,015	S	Form 4
VIR S Vir Biotechnology, Inc. SVF Endurance (Cayman) Ltd • 10% Owner 10b5-1 Sell 2025-11-26 $817,652 View Form 4 →
VIR	Vir Biotechnology, Inc.	SVF Endurance (Cayman) Ltd 10% Owner 10b5-1 Sell	2025-11-26	$817,652	S	Form 4
VIR S Vir Biotechnology, Inc. SVF Endurance (Cayman) Ltd • 10% Owner 10b5-1 Sell 2025-11-25 $1,505,495Large View Form 4 →
VIR	Vir Biotechnology, Inc.	SVF Endurance (Cayman) Ltd 10% Owner 10b5-1 Sell	2025-11-25	$1,505,495Large	S	Form 4
VIR S Vir Biotechnology, Inc. SVF Endurance (Cayman) Ltd • 10% Owner 10b5-1 Sell 2025-11-24 $1,400,783Large View Form 4 →
VIR	Vir Biotechnology, Inc.	SVF Endurance (Cayman) Ltd 10% Owner 10b5-1 Sell	2025-11-24	$1,400,783Large	S	Form 4
VIR S Vir Biotechnology, Inc. O'Byrne Jason • CFO Sell to Cover 2025-11-17 $37,782 View Form 4 →
VIR	Vir Biotechnology, Inc.	O'Byrne Jason CFO Sell to Cover	2025-11-17	$37,782	S	Form 4
VIR S Vir Biotechnology, Inc. de Verneuil Vanina • Officer • EVP, General Counsel, Corp Sec 10b5-1 Sell 2025-11-05 $12,307 View Form 4 →
VIR	Vir Biotechnology, Inc.	de Verneuil Vanina Officer • EVP, General Counsel, Corp Sec 10b5-1 Sell	2025-11-05	$12,307	S	Form 4
VIR S Vir Biotechnology, Inc. de Verneuil Vanina • Officer • EVP and General Counsel Sell to Cover 2025-11-03 $8,003 View Form 4 →
VIR	Vir Biotechnology, Inc.	de Verneuil Vanina Officer • EVP and General Counsel Sell to Cover	2025-11-03	$8,003	S	Form 4
VIR S Vir Biotechnology, Inc. SATO VICKI L • Director 10b5-1 Sell 2025-11-03 $124,047 View Form 4 →
VIR	Vir Biotechnology, Inc.	SATO VICKI L Director 10b5-1 Sell	2025-11-03	$124,047	S	Form 4
VIR S Vir Biotechnology, Inc. SVF Endurance (Cayman) Ltd • 10% Owner 10b5-1 Sell 2025-10-29 $649 View Form 4 →
VIR	Vir Biotechnology, Inc.	SVF Endurance (Cayman) Ltd 10% Owner 10b5-1 Sell	2025-10-29	$649	S	Form 4
VIR S Vir Biotechnology, Inc. SVF Endurance (Cayman) Ltd • 10% Owner 10b5-1 Sell 2025-10-28 $159,006 View Form 4 →
VIR	Vir Biotechnology, Inc.	SVF Endurance (Cayman) Ltd 10% Owner 10b5-1 Sell	2025-10-28	$159,006	S	Form 4
VIR S Vir Biotechnology, Inc. SVF Endurance (Cayman) Ltd • 10% Owner 10b5-1 Sell 2025-10-27 $401,585 View Form 4 →
VIR	Vir Biotechnology, Inc.	SVF Endurance (Cayman) Ltd 10% Owner 10b5-1 Sell	2025-10-27	$401,585	S	Form 4
VIR S Vir Biotechnology, Inc. SVF Endurance (Cayman) Ltd • 10% Owner 10b5-1 Sell 2025-10-24 $278,285 View Form 4 →
VIR	Vir Biotechnology, Inc.	SVF Endurance (Cayman) Ltd 10% Owner 10b5-1 Sell	2025-10-24	$278,285	S	Form 4
VIR S Vir Biotechnology, Inc. SVF Endurance (Cayman) Ltd • 10% Owner 10b5-1 Sell 2025-10-23 $924,723 View Form 4 →
VIR	Vir Biotechnology, Inc.	SVF Endurance (Cayman) Ltd 10% Owner 10b5-1 Sell	2025-10-23	$924,723	S	Form 4
VIR S Vir Biotechnology, Inc. SVF Endurance (Cayman) Ltd • 10% Owner 10b5-1 Sell 2025-10-22 $887,654 View Form 4 →
VIR	Vir Biotechnology, Inc.	SVF Endurance (Cayman) Ltd 10% Owner 10b5-1 Sell	2025-10-22	$887,654	S	Form 4
VIR S Vir Biotechnology, Inc. SVF Endurance (Cayman) Ltd • 10% Owner 10b5-1 Sell 2025-10-21 $690,974 View Form 4 →
VIR	Vir Biotechnology, Inc.	SVF Endurance (Cayman) Ltd 10% Owner 10b5-1 Sell	2025-10-21	$690,974	S	Form 4
VIR S Vir Biotechnology, Inc. SVF Endurance (Cayman) Ltd • 10% Owner 10b5-1 Sell 2025-10-20 $1,367,273Large View Form 4 →
VIR	Vir Biotechnology, Inc.	SVF Endurance (Cayman) Ltd 10% Owner 10b5-1 Sell	2025-10-20	$1,367,273Large	S	Form 4
VIR S Vir Biotechnology, Inc. SVF Endurance (Cayman) Ltd • 10% Owner 10b5-1 Sell 2025-10-16 $78,366 View Form 4 →
VIR	Vir Biotechnology, Inc.	SVF Endurance (Cayman) Ltd 10% Owner 10b5-1 Sell	2025-10-16	$78,366	S	Form 4
VIR S Vir Biotechnology, Inc. SVF Endurance (Cayman) Ltd • 10% Owner 10b5-1 Sell 2025-10-15 $101,196 View Form 4 →
VIR	Vir Biotechnology, Inc.	SVF Endurance (Cayman) Ltd 10% Owner 10b5-1 Sell	2025-10-15	$101,196	S	Form 4
VIR S Vir Biotechnology, Inc. SVF Endurance (Cayman) Ltd • 10% Owner 10b5-1 Sell 2025-10-10 $13,973 View Form 4 →
VIR	Vir Biotechnology, Inc.	SVF Endurance (Cayman) Ltd 10% Owner 10b5-1 Sell	2025-10-10	$13,973	S	Form 4
VIR S Vir Biotechnology, Inc. SVF Endurance (Cayman) Ltd • 10% Owner 10b5-1 Sell 2025-10-09 $1,529,926Large View Form 4 →
VIR	Vir Biotechnology, Inc.	SVF Endurance (Cayman) Ltd 10% Owner 10b5-1 Sell	2025-10-09	$1,529,926Large	S	Form 4
VIR S Vir Biotechnology, Inc. SVF Endurance (Cayman) Ltd • 10% Owner 10b5-1 Sell 2025-10-08 $2,819,785Large View Form 4 →
VIR	Vir Biotechnology, Inc.	SVF Endurance (Cayman) Ltd 10% Owner 10b5-1 Sell	2025-10-08	$2,819,785Large	S	Form 4
VIR S Vir Biotechnology, Inc. SVF Endurance (Cayman) Ltd • 10% Owner 10b5-1 Sell 2025-10-07 $404,154 View Form 4 →
VIR	Vir Biotechnology, Inc.	SVF Endurance (Cayman) Ltd 10% Owner 10b5-1 Sell	2025-10-07	$404,154	S	Form 4
VIR S Vir Biotechnology, Inc. SVF Endurance (Cayman) Ltd • 10% Owner 10b5-1 Sell 2025-10-06 $420,641 View Form 4 →
VIR	Vir Biotechnology, Inc.	SVF Endurance (Cayman) Ltd 10% Owner 10b5-1 Sell	2025-10-06	$420,641	S	Form 4
VIR S Vir Biotechnology, Inc. SVF Endurance (Cayman) Ltd • 10% Owner 10b5-1 Sell 2025-10-03 $2,501,785Large View Form 4 →
VIR	Vir Biotechnology, Inc.	SVF Endurance (Cayman) Ltd 10% Owner 10b5-1 Sell	2025-10-03	$2,501,785Large	S	Form 4
VIR S Vir Biotechnology, Inc. SATO VICKI L • Director 10b5-1 Sell 2025-10-01 $128,396 View Form 4 →
VIR	Vir Biotechnology, Inc.	SATO VICKI L Director 10b5-1 Sell	2025-10-01	$128,396	S	Form 4